CD36 and nonpapillary renal cell carcinoma: In the first series, progression and prognostic value of CD36 mRNA expression in ccRCC patients were assessed; in the second series, relationships between CD36 expression levels and anthropometric measures of obesity tissue were illustrated; in the third series, the role of VAT% predicts survival benefits in ccRCC patients.